Literature DB >> 646564

Mucormycosis. A complication of critical care.

W A Agger, D G Maki.   

Abstract

Lethal nosocomial mucormycosis developed in three previously well individuals while they were receiving intensive care for acute hemorrhagic pancreatitis, for cardiogenic shock, and for a ruptured intra-abdominal aortic aneurysm. In two cases, the condition was first seen as progressive cavitary pneumonia refractory to antibacterial therapy; Mucoraceae was identified in all three patients only at autopsy. Each patient had received large doses of corticosteroids and broad-spectrum antibiotics, and all had suffered from respiratory failure, acute renal failure with acidosis, and severe hyperglycemia in association with total parenteral nutrition. Mucoraceae should be regarded as an additional nosocomial pathogen in the setting of advanced life-support care.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646564     DOI: 10.1001/archinte.138.6.925

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Mucormycosis resulting in gastric perforation in a patient with acute myelogenous leukemia: report of a case.

Authors:  Kyo Young Song; Won Kyung Kang; Chong Won Park; Yeong Jin Choi; Sung Eun Rha; Cho Hyun Park
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 2.  Opportunistic zygomycotic infections. A literature review.

Authors:  A Espinel-Ingroff; L A Oakley; T M Kerkering
Journal:  Mycopathologia       Date:  1987-01       Impact factor: 2.574

3.  Myocardial infarction caused by cardiac disease in disseminated zygomycosis.

Authors:  E W Benbow; R F McMahon
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

4.  Orbital cellulitis due to mucormycosis. A case report.

Authors:  K Kotzamanoglou; G Tzanakakis; E Michalopoulos; M Stathopoulou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 5.  Unusual nosocomial infections.

Authors:  H C Neu
Journal:  Dis Mon       Date:  1984-10       Impact factor: 3.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.